
The journey for patients diagnosed with blood cancers such as leukemia, lymphoma, or multiple myeloma is often a harrowing path marked by aggressive treatments and unpredictable phases of illness, demanding a level of supportive care that extends far beyond a simple treatment plan. Artificial intelligence is now emerging as a transformative ally in this complex landscape, offering a way to










